Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Braz. j. infect. dis ; 24(1): 25-29, Feb. 2020. tab, graf
Article Dans Anglais | LILACS | ID: biblio-1089328

Résumé

ABSTRACT Background: To analyze the effectiveness and the safety of Sofosbuvir-based regimens to treat patients with chronic hepatitis C virus (HCV) infection and chronic kidney disease (CKD). Methods: A retrospective, observational study in patients with chronic HCV infection and CKD treated with Sofosbuvir-based regimens was performed. Liver fibrosis, comorbidities, HCV genotype and sustained virological resposnse (SVR) at 12th week post-treatment were evaluated. Kidney function was accessed by serum creatinine and glomerular filtration rate (GFR). The assumed level of significance was 5 %. Results: Thirty-five patients were treated. The mean age was 52.1 ± 10.9 years, 19 (54.3 %) were women, 32 (91.4 %) were already kidney transplanted and 3 (8.6 %) were on hemodialysis. The SVR by intention to treat was 88.6 %. The mean GFR was 65.8 ± 28.6 and 63.7 ± 28.3 ml/min pre- and post-treatment respectively (p > 0.05). Treatment was interrupted in 1 (2.85 %) patient due to anemia and in 2 (5.7 %) due to loss of kidney function. Conclusion: Sofosbuvir-based regimens are effective to treat HCV in patients with CKD. In patients with mild CKD this type of therapy seems to be safe.


Sujets)
Humains , Mâle , Femelle , Adulte , Adulte d'âge moyen , Sujet âgé , Antiviraux/usage thérapeutique , Hépatite C chronique/traitement médicamenteux , Insuffisance rénale chronique/physiopathologie , Sofosbuvir/usage thérapeutique , Indice de gravité de la maladie , Reproductibilité des résultats , Études rétrospectives , Analyse de variance , Transplantation rénale , Résultat thérapeutique , Statistique non paramétrique , Créatinine/sang , Insuffisance rénale chronique/thérapie , Réponse virologique soutenue , Débit de filtration glomérulaire , Imidazoles/usage thérapeutique , Immunosuppresseurs/usage thérapeutique
2.
Rev. AMRIGS ; 55(1, supl): 65-68, jan.-mar. 2011.
Article Dans Portugais | LILACS | ID: biblio-835325

Résumé

A síndrome de Miller Fisher (SMF), uma variante da Síndrome de Guillain-Barré, é uma doença incomum na prática médica. Esta doença é caracterizada por inflamação e desmielinização dos nervos periféricos de provável causa infecciosa. Estão descritos casos associados a infecções respiratórias e digestivas. O presente relato descreve o caso de uma paciente de 54 anos que apresentou SMF após sete dias de infecção urinária por Escherichia coli.


Miller Fisher syndrome (MFS), a variant of Guillain-Barré syndrome, is an uncommon disease in medical practice. It is characterized by inflammation and demyelination of peripheral nerves of probable infectious etiology. Cases are associated with respiratory and digestive infections. This report describes the case of a 54-year-old female patient who presented with MFS after seven days of urinary tract infection with Escherichia coli.


Sujets)
Humains , Femelle , Infections à Escherichia coli , Syndrome de Miller-Fisher , Polyradiculoneuropathie
SÉLECTION CITATIONS
Détails de la recherche